Case 18: Euglycemic Diabetic Ketoacidosis in a Patient With Type 1 Diabetes Treated With a Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor While on a Ketogenic Diet

Abstract

A 70-year-old female with unspecified diabetes presented to the emergency department complaining of nausea, dizziness, and anorexia for 4 days. She was diagnosed with diabetes at age 37 years. In her record, both type 1 diabetes and type 2 diabetes were listed as diagnoses. No prior C-peptide or serum antibodies were available. She had peripheral neuropathy and early stage 3 chronic kidney disease without proteinuria.